Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MTX1 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | C21orf2 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | ATP8B4 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | LGALS9 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | PTPN6 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | C16orf92 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | LINGO3 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | PKD1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | IL17RA | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | NEUROD2 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |